Wellcome Trust makes Ebola research investment

August 21, 2014
Research and Development, Sales and Marketing Africa, Ebola, Nigeria, deltas, welcome trust

The Wellcome Trust is launching a new multimillion pound initiative for emergency Ebola research coupled with a £40 million investment …

Paula Deen image

Celebrity-endorsed drug ads don’t work, says research

August 21, 2014
Medical Communications, Sales and Marketing advertising, bon jovi, dtc, healthcare marketing, paula deen, pharma

New research reveals the US system of using celebrity-endorsed drug adverts offer treatments more credibility but not influence when it …

warren_crawford

Masters Speciality Pharma hires head from Idis

August 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing masters speciality pharma, warren crawford

Masters Speciality Pharma has appointed Warren Crawford as a partner development director to lead and implement creative deal structures for …

GPs admit to wrongly prescribing antibiotics

August 20, 2014
Medical Communications, Sales and Marketing GPs, UK, doctors, longitude, prescribing, prize

Nearly half of British GPs surveyed have admitted to prescribing antibiotics unnecessarily due to uncertainty and a lack of diagnostic …

AstraZeneca image

AZ and Mitsubishi partner on diabetic nephropathy

August 20, 2014
Research and Development, Sales and Marketing AstraZeneca, BMS, Mitsubishi, cvmd, diabetes, nephropathy

AstraZeneca and Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) have signed a new three-year research deal in the area of …

Sanofi image

FDA approves Sanofi’s new rare disease drug

August 20, 2014
Research and Development, Sales and Marketing Elelyso, Gaucher disease, Genzyme, Sanofi, eliglustat

Sanofi’s biologics unit Genzyme has been granted approval for a new drug to treat the rare genetic disorder Gaucher’s disease. …

screen_shot_2014-08-20_at_08

New chief executive for Rabin Martin

August 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing jeffrey sturchio, rabin martin

US health consulting firm Rabin Martin has appointed Dr Jeffrey Sturchio as its new president and chief executive. Sturchio joined …

Brilinta image

Reprieve for AstraZeneca as US drops drug investigation

August 19, 2014
Sales and Marketing AstraZeneca, Brilinta, US, blood, justice, plato

The US Justice Department has pulled a controversial investigation into AstraZeneca’s pivotal clinical trial after finding no wrongdoing. The inquiry …

Sanofi image

Sanofi and PATH launch large-scale malaria drug production

August 19, 2014
Manufacturing and Production, Sales and Marketing Africa, Sanofi, acts, artemisinin, malaria, path

Sanofi and global health charity PATH have come together to launch a large-scale production line of malaria jab semisynthetic artemisinin …

miles_snowden

New chief medical officer for TeamHealth

August 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing miles, snowden, teamhealth

Outsourced doctor staffing US firm TeamHealth Holdings has appointed Dr Miles Snowden as the company’s chief medical officer (CMO). Snowden …

Freeman image

Science will ‘lose out’ if Scotland chooses independence

August 18, 2014
Research and Development, Sales and Marketing Conservative, Scotland, UK, george freeman, life sciences

The new minister for UK life sciences George Freeman has warned that independence from England “would damage Scotland’s edge in …

cancer image

Top four cancer killer rates ‘fall by a third’

August 18, 2014
Research and Development, Sales and Marketing CRUK, Cancer, bowel, charity, lung, prostate, research

Death rates for breast, bowel, lung and prostate cancer combined have fallen by almost a third in the last 20 …

Biogen image

FDA approves Biogen’s long-acting MS drug

August 18, 2014
Sales and Marketing Avonex, Biogen, FDA, MS, Rebif, plegridy, tecfidera

Biogen Idec has racked up another approval over the weekend after its latest multiple sclerosis treatment Plegridy gained FDA backing. …

Sales image

The end of salesmanship?

August 18, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Rose, a bpi, all trials, evidence, gold acre, sales, salesmanship

Although my specialism for the last 35 years has been clinical research, I actually started in the pharmaceutical industry as …

screen_shot_2014-08-18_at_07

Oxford BioMedica takes on executive position

August 18, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford BioMedica, blake

Gene and cell therapy firm Oxford BioMedica has confirmed that non-executive director Dr Paul Blake has been appointed to the …

Zytiga image

Charities ‘disappointed’ in NICE and Janssen

August 15, 2014
Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, prostate

The Institute of Cancer Research and Prostate Cancer UK are both urging NICE and Janssen to ‘get their act together’ …

catriona_hampton

Life hires principal writer from PAN

August 15, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Catriona Hampton, Life, Pan

Catriona Hampton has joined Life Healthcare Communications in Windsor, UK as a principal writer. Hampton who graduated in Immunology at …

SHL to exhibit at the 2014 PDA Conference in California, USA

August 15, 2014
Sales and Marketing auto injector, pda 2014, shl event, shl pda 2014

The growth of the auto injector industry has been driven largely in part by the need to improve patient compliance …

InterMune image

InterMune stock jumps on suitor claims

August 14, 2014
Sales and Marketing Boehringer, Esbriet, FDA, GSK, IPF, InterMune

Riding high of the success of its new lung drug Esbriet, InterMune has become the focus of some serious takeover …

Incivek image

Vertex ditches its once-stellar hep C drug

August 14, 2014
Sales and Marketing Gilead, Incivek, Vertex, hep C, sovaldi

Vertex will stop selling its once-blockbuster hepatitis C drug in the US this autumn after being crushed by new therapies. …

The Gateway to Local Adoption Series

Latest content